Which closed-end funds own Jazz Pharmaceuticals PLC?
4 active closed-end funds report this security in their latest N-PORT filing, with a combined reported value of $26.1M. Security type: loan. Country: Luxembourg. CUSIP FDSQ9B4Y8 · ISIN XAG5080AAJ16.
Holdings are historical filings (report dates Jun 30, 2026 – Jul 31, 2026; N-PORT becomes public ~60 days after quarter end), not live positions. Weights are percent of each fund’s net assets. Different instruments of one issuer (shares, bonds, preferreds) are separate securities — see related securities below.
Funds holding this security
| Fund | Category | Weight | Value (USD) | Balance | Fund net assets | Prem/disc | Report date |
|---|---|---|---|---|---|---|---|
| JFR Nuveen Floating Rate Income Fund | Senior Loans | 0.73% | $16.2M | 16,164,791 par | $2.2B | 10.4% discount | Jul 31, 2026 |
| JQC Nuveen Credit Strategies Income Fund | Taxable Bonds | 0.70% | $8.2M | 8,155,883 par | $1.2B | 13.4% discount | Jul 31, 2026 |
| JGH Nuveen Global High Income Fund | High Yield | 0.27% | $1.4M | 1,384,222 par | $508M | 13.4% discount | Jun 30, 2026 |
| NMAI Nuveen Multi-Asset Income Fund | Multi-Asset | 0.04% | $258K | 257,318 par | $691M | NAV unavailable | Jun 30, 2026 |
4 positions. Source: SEC Form N-PORT via market-data vendor re-serve. Funds without an N-PORT on file cannot appear here.
Also listed in filings as: Jazz Financing Lux Sarl.
Related securities from the same issuer
| Security | Type | Funds holding |
|---|---|---|
| Jazz Pharmaceuticals PLC | common equity | 3 |
| Jazz Pharmaceuticals PLC | common equity | 2 |
Issuer-level search for “Jazz Pharmaceuticals PLC” → · Compare two funds’ portfolios →